Search
for
Sort by
Research 181–210 of 1000+
- Comparative analysis of therapeutic outcomes in pediatric versus adult ophiasis-pattern alopecia areata: A review of treatment modalities and disease course
- The JAK/STAT signaling pathway: from bench to clinic
- BH02 Overcoming genetic drivers in alopecia areata: hair regrowth in a patient with the <i>AIRE</i> gene mutation treated with ruxolitinib
- The Possible Role of Antibodies in Alopecia: A Narrative Review
- BH08 Unprovoked pulmonary emboli in a patient with alopecia areata treated with ritlecitinib: a case report
- 63-Year-Old Female with Diffuse Thinning of the Hair
- Baricitinib: A Review in Severe Alopecia Areata
- Annual Convention in the Time of COVID
- Updates From 2021 Virtual Dermatology Nurses' Association Convention
- Studi Molecular Docking Aktivitas Anti Alopecia pada Senyawa yang Terkandung dalam Daun Dadap Serep (Erythrina subumbrans (Hassk.) Merrill)
- Progressive alopecia areata during TNF-α inhibition with intralesional corticosteroid failure and subsequent improvement following JAK1 inhibition
- Unraveling Ritlecitinib: an in-depth analysis of JAK3 inhibitor for the treatment of alopecia areata
- Ritlecitinib: First Approval
- Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition
- Efficacy and safety of ritlecitinib in adults and adolescents with alopecia areata: a randomised, double-blind, multicentre, phase 2b–3 trial
- ADVERSE EFFECTS OF RITLECITINIB IN ADULTS AND ADOLESCENTS WITH ALOPECIA AREATA: A LITERATURE REVIEW
- The Role of Janus Kinase Inhibitors in Dermatology
- Various Applications of Tofacitinib and Ruxolitinib (Janus Kinase Inhibitors) in Dermatology and Rheumatology: A Review of Current Evidence and Future Perspective
- Medicaid coverage of Janus kinase inhibitors for alopecia areata treatment
- Tumor necrosis factor inhibitors and janus kinase inhibitors in the treatment of cicatricial alopecia: A systematic review
- Janus kinase inhibitors for alopecia areata: a review of clinical data
- Comparative Efficacy Evaluation of Alopecia Areata Management with Janus Kinase Inhibitors in Children: Retrospective Cohort Study
- Clinical response to adjunctive platelet-rich plasma injections in a patient with alopecia universalis on oral tofacitinib
- Review of modern methods of treating vitiligo
- Evaluation of the efficacy and treatment-emergent adverse events of deuruxolitinib for moderate to severe alopecia areata: a dose-ranging meta-analysis of 1,372 randomized patients
- Treatment preferences of adults and adolescents with alopecia areata: A discrete choice experiment
- The role of janus kinases in the treatment of autoimmune skin diseases
- Efficacy and Safety of Ritlecitinib in the Asian Subpopulation of the ALLEGRO ‐2b/3 and ALLEGRO ‐ LT Clinical Studies for Alopecia Areata
- Deuruxolitinib for Alopecia Areata.
- Role of janus kinase inhibitors in the treatment of alopecia areata